These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 827926)
41. Homovanillic acid and 5-hydroxyindoleacetic acid cerebrospinal fluid levels. A study with and without probenecid administration of their relationship to the state of consciousness after head injury. Vecht CJ; van Woerkom CA; Teelken AW; Minderhoud JM Arch Neurol; 1975 Dec; 32(12):792-7. PubMed ID: 1203031 [TBL] [Abstract][Full Text] [Related]
42. Concentration of homovanillic acid and 5-hydroxyindoleacetic acid in the ventricular cerebrospinal fluid of patients with obstructive hydrocephalus. Kmieciak-Kolada K; Majchrzak H; Herman ZS J Neurol Neurosurg Psychiatry; 1979 Jan; 42(1):78-81. PubMed ID: 216782 [TBL] [Abstract][Full Text] [Related]
43. Monoamine metabolites in human cerebrospinal fluid: indicators of neuronal activity? Scheinin M Med Biol; 1985; 63(1):1-17. PubMed ID: 2582215 [TBL] [Abstract][Full Text] [Related]
44. Concentrations of 5-hydroxyindoleacetic acid and homovanillic acid in the cerebrospinal fluid of chronic therapy-resistant schizophrenics before and after hemodialysis therapy. Magnusson O; Fowler CJ; Ross SB; Schulman A; Wetterberg L Artif Organs; 1983 Aug; 7(3):344-8. PubMed ID: 6194776 [TBL] [Abstract][Full Text] [Related]
45. Acidic metabolites of dopamine and serotonin in cerebrospinal fluid. Sourkes TL Adv Neurol; 1974; 5():271-3. PubMed ID: 4440576 [No Abstract] [Full Text] [Related]
46. Parallel variation of homovanillic acid, 5-hydroxyindoleacetic acid and cyclic adenosine-3, 5-monophosphate in ventricular cerebrospinal fluid of man. Inagawa T Hiroshima J Med Sci; 1982 Jun; 31(2):117-21. PubMed ID: 6182129 [No Abstract] [Full Text] [Related]
47. Probenecid: dosage, levels in plasma and cerebrospinal fluid (CSF) and influence upon CSF levels of homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5-HIAA) in the rabbit. Muizelaar JP; Oberink JI Psychopharmacologia; 1975 Sep; 43(3):223-7. PubMed ID: 1187954 [TBL] [Abstract][Full Text] [Related]
48. Nonhomogeneous distribution of 5-hydroxyindoleacetic acid and homovanillic acid in the lumbar cerebrospinal fluid of man. Jakupcević M; Lacković Z; Stefoski D; Bulat M J Neurol Sci; 1977 Mar; 31(2):165-71. PubMed ID: 839230 [TBL] [Abstract][Full Text] [Related]
49. Concentration of 5-hydroxyindoleacetic acid, homovanillic acid, and tryptophan in the cerebrospinal fluid of depressed patients before and after ECT. Abrams R; Essman WB; Taylor MA; Fink M Biol Psychiatry; 1976 Feb; 11(1):85-90. PubMed ID: 1260078 [TBL] [Abstract][Full Text] [Related]
50. Cerebrospinal fluid neurotransmitter metabolites in neurologically normal infants and children. Langlais PJ; Walsh FX; Bird ED; Levy HL Pediatrics; 1985 Mar; 75(3):580-6. PubMed ID: 2579365 [TBL] [Abstract][Full Text] [Related]
51. Effect of ischemia on monoamine metabolism. Brain monoamine metabolites in cerebrospinal fluid of patients with recent cerebral infarction. Stelmasiak Z Neuropatol Pol; 1982; 20(1-2):97-105. PubMed ID: 6191248 [No Abstract] [Full Text] [Related]
52. Similar effects of tryptophan and sleep on cisternal cerebrospinal fluid 5-hydroxyindoleacetic and homovanillic acids in cats. Radulovacki M; Buckingham RL; Chen EH; Kovacević R Brain Res; 1977 Jul; 129(2):371-4. PubMed ID: 884510 [No Abstract] [Full Text] [Related]
53. [Metabolites of neurotransmitters in the cerebrospinal fluid in children]. Zeman J; Böswart J Cesk Pediatr; 1991 May; 46(5):262-5. PubMed ID: 1716526 [TBL] [Abstract][Full Text] [Related]
54. Higher CSF levels of HVA and 5-HIAA in delusional compared to nondelusional depression. Aberg-Wistedt A; Wistedt B; Bertilsson L Arch Gen Psychiatry; 1985 Sep; 42(9):925-6. PubMed ID: 2412522 [No Abstract] [Full Text] [Related]
55. Cerebrospinal fluid amine metabolic end-products: biochemical correlates of intelligence. Sishta SK; Templer DI Res Commun Chem Pathol Pharmacol; 1975 Nov; 12(3):601-4. PubMed ID: 128085 [No Abstract] [Full Text] [Related]
56. Effect of chlorpromazine treatment on monoamine metabolite levels in cerebrospinal fluid of psychotic patients. Wode-Helgodt B; Fyrö B; Gullberg B; Sedvall G Acta Psychiatr Scand; 1977 Aug; 56(2):129-42. PubMed ID: 899844 [TBL] [Abstract][Full Text] [Related]
57. Effects of tiapride on homovanillic acid levels in human cerebrospinal fluid drawn at pneumoencephalography. Spissu A; Congia S; Piccardi MP; Fadda F; Mangoni A; Gessa GL Psychopharmacology (Berl); 1980; 71(1):7-9. PubMed ID: 6161384 [TBL] [Abstract][Full Text] [Related]
58. The effect of lithium treatment on manic symptoms and levels of monoamine metabolites in cerebrospinal fluid of manic depressive patients. Fyrö B; Petterson U; Sedvall G Psychopharmacologia; 1975 Oct; 44(1):99-103. PubMed ID: 1105629 [TBL] [Abstract][Full Text] [Related]
59. [Levels of homovanillic acid and 5-hydroxyindoleacetic acid in the cerebrospinal fluid in patients with focal cerebral ischemia]. Chavko M; Kehr J; Vasková M; Eiben E Cesk Neurol Neurochir; 1989 Oct; 52(6):403-8. PubMed ID: 2483951 [TBL] [Abstract][Full Text] [Related]
60. Neurophysiological measures related to levels of 5-hydroxyindoleacetic acid, homovanillic acid and tryptophan in cerebrospinal fluid of psychiatric patients. Gottfries CG; von Knorring L; Perris C Neuropsychobiology; 1976; 2(1):1-8. PubMed ID: 1004696 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]